|
Name |
Macrosphelide C
|
| Molecular Formula | C16H22O7 | |
| IUPAC Name* |
(4S,7E,10S,13E,15R,16S)-15-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione
|
|
| SMILES |
C[C@H]1C/C=C/C(=O)O[C@H](CC(=O)O[C@H]([C@@H](/C=C/C(=O)O1)O)C)C
|
|
| InChI |
InChI=1S/C16H22O7/c1-10-5-4-6-14(18)22-11(2)9-16(20)23-12(3)13(17)7-8-15(19)21-10/h4,6-8,10-13,17H,5,9H2,1-3H3/b6-4+,8-7+/t10-,11-,12-,13+/m0/s1
|
|
| InChIKey |
LHDGUPDIEZSEGS-HRABQTKNSA-N
|
|
| Synonyms |
Macrosphelide C; (4S,7E,10S,13E,15R,16S)-15-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione; 199731-56-1
|
|
| CAS | NA | |
| PubChem CID | 11198166 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 326.34 | ALogp: | 1.4 |
| HBD: | 1 | HBA: | 7 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 99.1 | Aromatic Rings: | 1 |
| Heavy Atoms: | 23 | QED Weighted: | 0.532 |
| Caco-2 Permeability: | -4.486 | MDCK Permeability: | 0.00006340 |
| Pgp-inhibitor: | 0.713 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.035 |
| 30% Bioavailability (F30%): | 0.999 |
| Blood-Brain-Barrier Penetration (BBB): | 0.977 | Plasma Protein Binding (PPB): | 58.95% |
| Volume Distribution (VD): | 0.278 | Fu: | 32.99% |
| CYP1A2-inhibitor: | 0.017 | CYP1A2-substrate: | 0.037 |
| CYP2C19-inhibitor: | 0.019 | CYP2C19-substrate: | 0.058 |
| CYP2C9-inhibitor: | 0.015 | CYP2C9-substrate: | 0.137 |
| CYP2D6-inhibitor: | 0.015 | CYP2D6-substrate: | 0.132 |
| CYP3A4-inhibitor: | 0.212 | CYP3A4-substrate: | 0.24 |
| Clearance (CL): | 8.833 | Half-life (T1/2): | 0.94 |
| hERG Blockers: | 0.003 | Human Hepatotoxicity (H-HT): | 0.164 |
| Drug-inuced Liver Injury (DILI): | 0.519 | AMES Toxicity: | 0.715 |
| Rat Oral Acute Toxicity: | 0.029 | Maximum Recommended Daily Dose: | 0.953 |
| Skin Sensitization: | 0.946 | Carcinogencity: | 0.848 |
| Eye Corrosion: | 0.997 | Eye Irritation: | 0.425 |
| Respiratory Toxicity: | 0.039 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003788 | ![]() |
0.726 | D06WTZ | ![]() |
0.246 | ||
| ENC005849 | ![]() |
0.726 | D0H0ND | ![]() |
0.241 | ||
| ENC001946 | ![]() |
0.718 | D0K7LU | ![]() |
0.233 | ||
| ENC005850 | ![]() |
0.703 | D02FEM | ![]() |
0.231 | ||
| ENC003456 | ![]() |
0.452 | D03DIG | ![]() |
0.214 | ||
| ENC001860 | ![]() |
0.388 | D0J7OG | ![]() |
0.213 | ||
| ENC001867 | ![]() |
0.353 | D0X1WJ | ![]() |
0.211 | ||
| ENC003403 | ![]() |
0.353 | D0L6QI | ![]() |
0.210 | ||
| ENC002189 | ![]() |
0.342 | D0WE3O | ![]() |
0.208 | ||
| ENC001414 | ![]() |
0.333 | D05AFC | ![]() |
0.206 | ||